Briacell Therapeutics Corp (BCTX) — Cash Flow Reinvestment Rate
Briacell Therapeutics Corp (BCTX) has a Cash Flow Reinvestment Rate of 0.00x as of April 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $22.57K. Explore BCTX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Briacell Therapeutics Corp Cash Flow Reinvestment Rate (2006–2006)
Historical reinvestment intensity for Briacell Therapeutics Corp across 1 annual periods. Also explore how large is Briacell Therapeutics Corp's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Briacell Therapeutics Corp (2006–2006)
Year-by-year capital reinvestment analysis for Briacell Therapeutics Corp. For live market cap and broader valuation context, see BCTX market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.00x | $0.00 | $1.13K | $0.00 | — |